Dimitrios Bliagos, MD
Interventional Cardiology · White Plains, NYNPI 1013164201
Payments from drug & device makers
Across 435 payments — averaging $141.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$24K
- Shockwave Medical, Inc$11K
- Medtronic$11K
- Magenta Medical Inc$6K
- Abiomed$5K
- Abbott$2K
- plus $3K from 16 others
Across 5 payments — averaging $63.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abiomed$319
What the payments were for
- Consulting fees$13,90023%
- Speaking & faculty fees$26,95344%
- Travel & lodging$5,0598%
- Food & beverage$15,73626%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 110 | $24,063 |
| Shockwave Medical, Inc | 13 | $10,972 |
| Medtronic(2 entities) | 100 | $10,917 |
| Magenta Medical Inc | 3 | $5,632 |
| Abiomed | 79 | $5,365 |
| Abbott | 39 | $1,568 |
| Cardiovascular Systems Inc. | 28 | $503 |
| Asahi Intecc USA, Inc. | 12 | $484 |
| Edwards Lifesciences | 3 | $354 |
| Teleflex LLC | 4 | $347 |
| Terumo Medical Corporation | 3 | $310 |
| Biosense Webster, Inc. | 2 | $235 |
| AstraZeneca | 11 | $231 |
| Chiesi USA, Inc. | 10 | $194 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $191 |
| Arrow International, Inc. | 1 | $116 |
| Novartis | 2 | $47 |
| Pfizer | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Penumbra, Inc. | 1 | $18 |
| Philips North America LLC | 1 | $17 |
| Amgen | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$10,827
- Resolute$7,825
- Impella$4,012
- GENERAL VASCULAR ACCESS$4,000
- AVVIGO Guidance System$1,720
- SYMPLICITY G3$426
- GUIDELINER$321
- COREVALVE EVOLUT R$306
- Optis Coronary Imaging System$263
- OPTIS$250
- RESOLUTE ONYX$246
- CoreValve Evolut$239
- Carto 3$235
- OCTARAY MAPPING CATHETER$235
- METACROSS OTW$209
- ANGIO-SEAL$209
- Heartrail$201
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$187
- ROTAPRO$168
- STINGRAY$168
How this compares
$61,647 in reported general payments places this provider in the 75th percentile of 382 interventional cardiology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 14 | $40 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in White Plains
- Martin LeonNew York$13.5M
- David CohenRoslyn$9.8M
- Susheel KodaliNew York$6M
- Mohamed Azeem LatibBronx$4.6M
- Richard ShlofmitzRoslyn$4.5M
- Deepak BhattNew York$4.1M
- Samin SharmaNew York$3.7M
- Annapoorna KiniNew York$3.5M
- Sahil ParikhNew York$2.7M
- George DangasNew York$2.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.